The Senate has yet to release a broad-based medical products reform bill to parallel the rapidly moving "21st Century Cures" legislation in the House, but individual medical device reform provisions are surfacing in the upper chamber, including the FDA Device Accountability Act introduced June 18.
The bill, sponsored by Republican Sen. Richard Burr (N.C.) and Democratic Sen. Al Franken (Minn.), includes three provisions that mirror sections in the House's Cures package that was passed by...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?